Mutations in SCN5A can alter the cardiac sodium current INa and increase the risk of potentially lethal conditions such as Brugada and long-QT syndromes. The relation between mutations and their clinical phenotypes is complex, and systems to predict clinical severity of unclassified SCN5A variants perform poorly. We investigated if instead we could predict changes to INa, leaving the link from INa to clinical phenotype for mechanistic simulation studies. An exhaustive list of nonsynonymous missense mutations and resulting changes to INa was compiled. We then applied machine-learning methods to this dataset, and found that changes to INa could be predicted with higher sensitivity and specificity than most existing predictors of clinical significance. The substituted residues’ location on the protein correlated with channel function and strongly contributed to predictions, while conservedness and physico-chemical properties did not. However, predictions were not sufficiently accurate to form a basis for mechanistic studies. These results show that changes to INa, the mechanism through which SCN5A mutations create cardiac risk, are already difficult to predict using purely in-silico methods. This partly explains the limited success of systems to predict clinical significance of SCN5A variants, and underscores the need for functional studies of INa in risk assessment.
The human gene SCN5A encodes the pore-forming α-subunit of the cardiac sodium channel Nav1.5, which carries INa, the fast sodium current. INa is responsible for the initial rapid upstroke of the cellular action potential (AP) and a major determinant of electrical propagation in the heart1. Mutations in SCN5A can alter both the magnitude and the shape of INa, which – in conjunction with other factors – can predispose carriers to clinical phenotypes including Brugada syndrome, long-QT syndrome, and conduction disorders2. These conditions increase the risk of potentially lethal cardiac arrhythmias and have been associated with hundreds of SCN5A mutations3,4,5,6.
New unclassified variants are regularly found, but predicting their pathogenicity has proven an exceedingly difficult task. For example, Leong et al.7 assessed the performance of commonly used in-silico prediction tools (PolyPhen-2, SNPs&GO, SIFT, PROVEAN, and SNAP), on variants in SCN5A and the potassium channel genes KCNQ1 and KCNH2. They found that KCNQ1 and KCNH2 predictions were generally good, while predictions of SCN5A pathogenicity were little better than chance – as evinced by low values for the area under the receiver-operating curve (AUC) and the Matthews correlation coefficient (MCC). Similarly, Brunklaus et al.8 reviewed variants and phenotypes in all human voltage-gated sodium channel types. For SCN5A variants they found that, while there were some correlations, the “exact biophysical impact” of variants could not be predicted, and clinical patient management should instead be based on functional in-vitro or in-vivo studies.
One reason for the poor SCN5A performance of these statistical machine-learning9 methods may be that they make no use of mechanistic knowledge of cardiac electrophysiology. Instead, they take information about variants, for example the site of the substitution, the prevalence of this variant in the population, or the physico-chemical properties of the affected amino acids, and then try to establish a direct, ‘black-box’ link to pathogenicity. In several cases, however, the proarrhythmic mechanisms associated with a specific SCN5A mutation have been established using a systems approach that follows genetic screening by current measurements in expression systems, and then uses mathematical modelling to show how they can lead to the observed cell, tissue, and ECG effects10,11,12. While this approach has traditionally been applied to investigate single mutations with known clinical phenotypes, a study on long-QT syndrome type 1 by Hoefen et al.13 clearly demonstrated that (1) this approach can be extended to cover multiple mutations (provided their effects on the ion current are known), and (2) that the resulting models can predict clinical outcomes and improve risk stratification. Moreover, mechanistic models make it possible to evaluate the arrhythmogenic potential of SCN5A variants under different conditions, since it is well-accepted that, e.g., heart rate and autonomic tone play a critical modulating role14. Similarly, it is increasingly clear that the diseases associated with SCN5A are not monogenic, and may involve a large number of modifier genes15; mechanistic models can be made to include these effects, creating models personalised to a specific genetic context. It seems pertinent then to incorporate such mechanistic modelling into in-silico pathogenicity predictions.
In the present study, we aimed to establish whether machine-learning methods could be used to predict functional changes to INa from non-synonymous missense mutations in SCN5A. If successful, this reduced machine-learning step (from gene to ion current) could then be followed by a mechanistic modelling step (from ion current to clinical phenotype) to create a two-stage in-silico predictor. In addition to new capabilities (e.g., incorporating patient-specific co-morbidities) this approach would move factors such as non-linear ion-current interactions and action-potential propagation from the first, machine-learning stage, to the secondary mechanistic modelling stage, where they could be addressed more naturally. For the first stage, which is the one we address in this study, we expected the resulting reduction in complexity to lead to a significant improvement in the quality of predictions.
To see if we could predict changes to INa resulting from mutations, we conducted a comprehensive literature review of reported variants in SCN5A for which cellular electrophysiology (EP) data was available. For each variant, we collected a set of features, such as the substitution site (including aspects such as proximity to the voltage sensor), physico-chemical properties of the substituted amino acids (e.g., differences in charge, differences in hydrophobicity, and their Grantham similarity score, see “Machine-learning features”), and the conservedness of that site between human channel isoforms.
As outcomes, we noted when substitutions altered voltage-dependence or kinetics of activation, affected inactivation (including recovery), affected the late component of INa, abolished the current completely, or any of the above. We then evaluated the power of machine-learning techniques such as Naive Bayes (used in PolyPhen16), support vector machines (used in SNPs&Go17), and neural networks (used in SNAP18) to predict the outcomes from the features. An overview of our methods is shown in Fig. 1.
Figure 2 Shows a schematic overview of Nav1.519, with its four domains, each featuring six transmembrane segments (shaded regions). The fourth segment in each domain is sensitive to changes in voltage, and the linker between segments 5 and 6 is known to fold back into the membrane to create the channel pore20. Both the C-terminus and the linker between domains III and IV have been suggested to be involved in inactivation and the late component of INa21. SCN5A mutations are found throughout the gene, and mutations have been reported in the clinical/biophysical literature for every transmembrane segment and every linker in the protein. By far most studies report a significant change in INa (Fig. 2). Whereas many studies focus on the key regions mentioned above, many variants outside of these sensitive areas have also been linked to arrhythmia, and conversely many mutations inside sensitive areas do not significantly alter INa. A numerical view of the data is shown in Table 1 and a further breakdown of changed/unchanged EP per area is given in section 6 of the Supplement.
We gathered 378 reports of EP-data measurements19. As several studies investigated the same variants (either confirming previous work or addressing new aspects), we found cellular EP for 243 variants. The final row in Table 1 gives the total number of possible amino-acid substitutions arising from a single nucleotide change in SCN5A before and after removing duplicate gene products. This was calculated by listing all nucleotide substitutions in the coding region of SCN5A and noting which ones resulted in an amino-acid switch (not including stop codons). From this we calculated that there are approximately 11923/2016 ≈ 5.91 possible mutations per position in the gene, so that while Fig. 2 accurately reflects the positions at which variants are known, it should not be taken as an indication of the coverage of our dataset, which it overstates by about six times. A list of variants and the resulting changes in cellular EP is given in section 11 of the Supplement.
We next investigated the estimated relative mutation densities in different regions of the channel19 (Fig. 3, details of how this was calculated can be found in the Methods section). The variants used for this figure were all reported in the literature on cardiac arrhythmias and cardiomyopathies (see the section “Finding mutations in the literature”). The voltage-sensing fourth segment was found to have the highest relative mutation density. Although many variants were reported in the C- and N-terminus, their large size resulted in a low mutation density. Differences between the same regions in different domains were found. For example, the linker between segments 3 and 4 was found to have a higher-than-average mutation density in domains 1, 3 and 4 but a lower-than-average density in domain 2. Comparing domains revealed similar differences, with variants in domain 2 being relatively uncommonly reported while domains 3 and 4 were most likely to contain variants reported in the scientific literature. Due to its short length, and perhaps its role in inactivation, the linker between domains 3 and 4 was found to have a very high mutation density.
These results all indicate that there is a relationship between position on the gene and function, although this relationship may not be straightforward. To further investigate these structure-function relationships, we plotted the number and type of reported changes to INa in Fig. 4 Mutations leading to a channel that failed to produce any current occured predominantly in the pore-forming linker between segments 5 and 619. This suggests that changes to the pore were investigated more often than mutations abolishing current through other mechanisms (e.g., extreme changes in voltage dependence or trafficking and folding defects). Among the transmembrane segments, the voltage-sensing fourth segment was the main contributor of changes in activation, but surprisingly the domain linkers were almost equally prone. However, the number of changes in activation per amino acid was much higher in the fourth segment than anywhere else in the gene. Changes to inactivation were common in the voltage-sensing segment, but also occurred frequently in the domain linkers and the C-terminus. Surprisingly, the linker between domains 3 and 4 showed very few mutations affecting inactivation, but this may be explained by its relatively small size. Most mutations affecting late INa were found in the domain linkers and C-terminus. In general, mutations affecting the late component of INa were found in regions also affecting inactivation, supporting the idea that late INa is connected to a failure to fully inactivate.
These results are consistent with previous reports of INa structure-function relationships19. For example, Kapa et al.22 investigated the predictive value of different SCN5A regions when predicting pathogenicity of long-QT syndrome. They found a strong link between long-QT pathogenicity and the transmembrane segments and the C-terminus, which agrees with our finding that these regions are linked to changes in the late component of INa. While Fig. 4 shows a connection between the domain linkers and the late component, no such link was established in the study by Kapa et al., but this may be explained by our larger dataset and SCN5A -specific approach. Motoike et al.21 showed that inactivation and late INa are associated with both the C-terminus and the linker between domains 3 and 4. Our results confirm this role of the C-terminus, but indicate that while the 3-4 linker has a very high mutation density, the absolute number of mutations affecting inactivation and late INa is similar to the other domain linkers. Observations like these, i.e., the existence of inactivation-affecting mutations in regions not known to play a part in inactivation, could indicate a novel role for these regions. However, it is difficult to judge if their scarcity is a sign of low importance (causing them to surface in clinical investigations only rarely), of high importance (causing them to be hidden by incompatibility with life), or mere coincidence (see “Discussion”).
We next sought to relate the changes in EP to changes in the physico-chemical properties of the substituted amino-acids (Fig. 5). Changes in charge were only marginally more common for variants affecting activation and inactivation than for unaffected cases19. Large changes to α-helix propensity were uncommon regardless of the associated EP-change. Some structure appears due to the discrete nature of the data (there are at most 20 different values per property, corresponding to the 20 amino acids), some banding appears in the graph, notably creating gaps near zero for e.g., volume. However, no other striking patterns emerge. There were no significant differences between the groups (see section 8 of the Supplement for details).
We next addressed the question of which patterns, if any, could be found in the amino-acid substitutions of reported mutations. We calculated the ratio between observed and expected frequency of each x to y transition (where x and y represent one of the 20 amino acids)19. We found that certain replacements, for example arginine (R, positive charge) to histidine (H, positive charge) were seen much more often than expected, and that, in general, R was 4 times more likely to be replaced than average while tryptophan (W) was the most common substitute. However, we were unable to connect these observations to the physico-chemical properties of the amino acids. For example, charge conservation was over-represented in some cases (R to H) and under-represented in others (aspartic acid, D to glutamic acid, E). Full details are given in section 7 of the Supplement.
Taken together, the findings indicate that changes in individual amino acids are unsuitable to accurately predict the effects of an SCN5A variant on INa.
To determine if quantitative predictions about the magnitude of the EP change could be made, we investigated mutations that caused a shift in the midpoint of activation or inactivation19. In Fig. 6 the size of these shifts is plotted against position in the gene. Again large effects were not restricted to key areas, but observed throughout the gene. However, compared to the other transmembrane segments, the fourth segment stood out due to the large number of variants, and many large shifts were seen.
Having inspected the data, we investigated whether machine-learning methods could detect structure not easily visible with the human eye. A separate dataset was created for each of the five outcomes (EP changed, activation changed, inactivation changed, late component changed, current diminished completely), creating five independent machine-learning problems. We then tested several different methods, each based on a different underlying principle, on these five problems. Table 2 shows the best results obtained for each problem, along with the method that performed best. We show accuracy (percentage of correct predictions), along with area under the receiver-operating (ROC) curve and MCC. The result from a ‘Zero-R’ classifier, which provides a baseline for comparison, are shown in brackets behind each number. ROC curves for the best-performing classifiers for the ‘inactivation’ and ‘zero current’ problems are shown in Fig. 7.
For both activation and inactivation, only a modest improvement on baseline accuracy was made, but AUC and MCC could be improved considerably19. Predicting changes to the late component proved most difficult, with the best-performing classifier showing an MCC of only 0.061. The best results were obtained for the ‘zero current’ problem, although only a small number of variants abolished INa completely, leading to a very high baseline (Zero-R) accuracy of 87.7%. Predicting if the current produced any change in INa proved more difficult: although an MCC of 0.239 was reached this required sacrificing predictive accuracy, which was below the Zero-R baseline. This might be explained by the fact that the changed/unchanged problem encompasses the other four problems, and is therefore potentially more difficult.
For comparison, we also included the MCCs given by Leong et al.7 for direct pathogenicity prediction using five common methods, as well as the best-performing combination of those five. Interestingly, our changed/unchanged predictions showed a similar MCC to the more established tool SNAP, and outperformed the other methods (except for the combined SNAP & Provean meta-classifier). The ‘zero current’ problem (which can have a severe clinical phenotype) could be predicted with a higher MCC than any existing tool or combination of tools. These results suggest that some changes to INa can be predicted more reliably than pathogenicity.
We next ranked the different features (variant properties) from the highest to the lowest information gain19,23. For the inactivation problem, the most useful properties were region type (N-terminus, segment 1, linker 5-6, etc.), the distance to the pore-forming linker between segments 5 and 6 (where distance was measured by counting the number of residues on the protein), the distance to segment 5 and the distance to the linker between domains 3 and 4. Region type was the most useful feature for all four problems, and only the zero-current dataset assigned a non-zero information gain to any of the physical amino-acid properties. Even difference in charge resulted in a very small information gain in the voltage-dependent activation problem, which is consistent with the findings in Fig. 5. The information-gain rankings for each problem are given in section 9 of the Supplement.
Finally, we assessed the performance of the same methods on the problem of predicting discretised shifts in activation and inactivation (e.g., predicting if the shift in midpoint of activation was more positive than 3 mV, more negative than −3 mV, or between −3 mV and 3 mV)19. The results for inactivation are shown in Table 3. Here, the Random forest method performed best, but overall accuracy was low. Similar results were obtained for activation (not shown).
Predictors of SCN5A variant pathogenicity suffer from poor performance. We hypothesised that taking a smaller leap, from SCN5A variants to changes in INa, would reduce the complexity of this problem and lead to improved predictions. To test this, we assembled a large dataset containing information about non-synonymous SCN5A missense mutations reported in the literature on channelopathies and cardiomyopathies, and the resulting changes to INa19.
We found that missense mutations occur throughout the gene, but with a higher rate per amino acid in transmembrane segments 4 and 6 than in any other segment19. The linkers between domain 1-2 and 2-3 showed a lower than average mutation density, but a high density was seen in the linker between domains 3 and 4. Of the four domains, domain 2 had the lowest mutation density.
Changes in function correlated with the location of the variant on the gene19. Complete absence of current was often observed for variants in the pore-forming linkers between segment 5 and 6. Effects on inactivation were mainly seen in the voltage-sensing 4th segment, the 6th segment, the domain linkers and the C-terminus. This is consistent with earlier findings by Brunklaus et al.8, who showed variants in these regions were often implicated in long-QT syndrome type 3. Mutations influencing late INa often occurred in the C-terminus, and appeared mostly in areas also affecting inactivation.
The reported amino-acid substitutions did not occur with the frequencies that would be expected based on unbiased single nucleotide changes19. Instead, arginine substitutions were strongly overrepresented in our dataset, while tryptophan was the most common substitute residue. However, no strong relationship between the change in amino-acid properties and the variant’s electrophysiological effects could be seen.
We applied five different machine-learning techniques to the problems of predicting qualitative changes in EP19. In terms of accuracy, no major improvements over baseline (i.e., the performance of a Zero-R classifier) were seen. However, better-than-chance AUCs and MCCs were obtained. The region type (see “Machine-learning features”) was found to be the most informative feature of a variant in all four problems examined. Again, the physical properties of the exchanged amino acids provided little information.
By comparing our results to previous work by Leong et al.7, we found that full reduction of current and changes to activation and inactivation can be predicted with higher MCCs than achieved by direct predictors of pathogenicity. This supports our hypothesis that INa changes can be predicted more reliably than pathogenicity. However, the best combination of tools (SNAP & PROVEAN) achieved comparable results, so the difference is not as great as might have been expected. Overall, the performance of all methods was good in terms of AUC and MCC, but still failed to deliver the accuracy needed to create a two-stage in-silico predictor. This suggests that fully in-silico predictions of unclassified SCN5A variant pathogenicity, either direct or indirect, are still out of reach. Instead, our results underscore the need for functional in-vitro studies to assess the risks posed by SCN5A variants.
The predictive power of a dataset depends on three critical factors: it must contain enough information, it must be unbiased (balanced), representing equally plausible outcomes in equal measures, and it must be internally consistent19. Once a dataset meeting these criteria is available, it must be reformatted in such a way that each variant is represented by appropriate features. These are properties that are indicative of some essential aspect of the substitution, such as its location in the protein or the associated change in electrical charge. The information gain per feature (shown in section 9 of the Supplement) was low or zero for many of the selected features, indicating that this is an area where improvements can be made.
Considering the work that goes into measuring the cellular EP changes due to a mutation, the total number of 378 EP recordings of 243 unique variants is an impressive achievement by the collective scientific community. As shown in section 3 of the Supplement, the number of EP data reports for SCN5A variants has steadily increased each year19. One development that could lead to dramatic increases in data is the inclusion of paralogues24,25. This entails aligning the sequence of SCN5A with that of highly similar sodium channel genes (i.e., SCN1A, SCN2A, SCN3A, etc) and using data about their variants for similar positions in SCN5A. Besides increasing the size of the dataset, care must be taken to improve the manner in which experimental conditions are reported, perhaps using a scheme such as outlined by Quinn et al.26. For example, while variations in the α-subunit are known to affect INa properties27, and while sequencing methods and unique clone IDs are now readily available, a significant fraction of experimental reports still do not state the exact α-subunit used (see section 4 of the Supplement for details). Our approach therefore necessarily mixes data from different α-subunit varieties. If future experiments all include the most common Q1077del isoform and provide accession numbers for each subunit they use, this limitation can be overcome.
Almost all of the variants listed in our database were reported as a result of a clinical investigation of patients with some pathological cardiac phenotype; accordingly only 28% of EP-data results in our dataset showed no change. Indeed, the variants we report as ‘unchanged’ were almost exclusively published in papers reporting that an effect was seen in the presence of a secondary factor (for example the common polymorphism H558R or drugs such as lidocaine)19. Imbalanced datasets, such as the ones considered in the present study, pose well-known difficulties for machine-learning algorithms; as they will be biased towards the majority group28. In agreement, the least biased dataset in our study (zero current predictions) showed the highest AUC and MCC, underscoring the need to improve balance in the dataset and further reduce this reporting bias. The lack of balance in our datasets may also explain why the simpler machine-learning methods (Naive Bayes, Nearest neighbour) outperform more complex methods (e.g., support-vector machines and the MLP classifier), as their more limited ability to fit to complex patterns in the training data can help prevent overfitting.
Compatibility with life provides a more subtle bias: since mutations that prevent all current (such as frameshift mutations or trafficking defects) are still commonly reported, it seems that if a heterozygous mutation renders a channel completely ineffective, the body can compensate by upregulating the overall production of cardiac sodium channels or downregulating others29. By contrast, gain-of-function mutations that seem less extreme from a biophysical perspective (e.g., ones that cause a strong increase in late INa or a large leftward shift in voltage-dependence, but do not fully prevent any current) may be incompatible with life even heterozygously, causing them to be under-represented in our dataset. There is also a chance that a non-functioning heterozygously expressed channel interferes with the unmutated channel via dominant-negative α-α-subunit interaction19,30.
Addressing the problem of dataset bias requires a targeted approach19. Using Fig. 3 and the amino acid substitution rates given in section 7 of the Supplement as a guide, variants in under-represented areas or with uncommon amino-acid substitutions could be identified and investigated. This would involve investing resources into variants with no clear clinical significance, but would greatly increase the value of the combined EP data gathered so far. A cheaper alternative may be to put out a call to all labs harbouring unpublished negative data to process and publish it, ideally in a freely accessible online database.
In our dataset, more than one EP data report exists for 74 variants, and some inconsistencies can be seen for 43 of those19 (58%; see section 5 of the Supplement for two examples). For figures such as Fig. 4, which dealt with EP data classes (activation, inactivation, etc.) we used a voting system to resolve conflicts (see “Electrophysiological characterizations”). For numerical data (midpoint shifts) we used a filtered version of the dataset in which conflicts were resolved by selecting the favoured experimental conditions. In the future, when even more data is available, it may be possible to select only a subset of the data that conforms to a certain experimental set-up. This will resolve the issue of different experimental conditions, but the best way to deal with remaining conflicts is an open issue.
Creating a workable predictor will require finding features that capture the difference in physical properties before and after an amino-acid substitution. The current set of features was chosen based on mechanistic reasoning (e.g., the location and physico-chemical properties of the amino acids can be presumed to affect channel function), and ideas from the literature (e.g., inclusion in or proximity to the voltage sensor is often quoted as a reason that a mutation could be important to channel function). However, the current list is not exhaustive, and the information-gain figures in section 9 of the Supplement further show that not all features are useful for classification. Hence, the need for more descriptive features is a clear outcome of this first study. One approach could be to build a full physical model and use molecular-dynamics methods to compare channel structure before and after a mutation19. However, such models are usually based on homology models that do not include the important domain linking segments and terminals, and molecular-dynamics simulations are computationally very expensive. An alternative approach may be to segment the gene, for example using the ‘basic units of protein structure’ proposed by Berezovsky et al.31, and then to inspect the amino-acid properties on a per-segment basis or via the calculation of three-dimensional ‘moments’32.
In conclusion, the effects of missense mutations in SCN5A on INa are difficult to predict using machine-learning methods. However, our first attempts at solving this problem already provide more reliable predictions than established methods for solving the more complex problem of predicting pathogenicity. Our approach can be further improved by expanding the size of the dataset, reducing its reporting bias, and finding features that better characterise the effects of a mutation on Nav1.5 structure. These results underscore the need for functional studies, for example in-vivo experiments or cellular expression systems combined with computational modelling, when assessing the impact of mutations in SCN5A.
Finding mutations in the literature
To find publications on SCN5A missense mutations, we scanned through all PubMed results for the term ‘ SCN5A mutation’19. In addition, we screened previously published overview papers3,4,5,34,35,36,37. From the selected papers, we listed all nonsynonymous missense mutations for which cellular EP data was known, or which were associated with a pathological clinical phenotype. Because we focused on changes to channel function, we only noted amino-acid substitutions, without investigating the underlying nucleotide change. Common polymorphisms such as H558R were treated as variants, and included in the database as such. Reports investigating variants in the presence of H558R were treated as double variants, and excluded from our database.
Numbering of amino acids
In numbering the mutations, we used the position on the full, 2016 residue long sequence for human SCN5A (Isoform 1, GenBank accession number AC137587). In some cases this meant using a different numbering than in the original source19.
Where possible, we collected information about the changes to whole-cell INa resulting from each mutation19. First, we asked whether or not the mutated channel conducted a current large enough to measure (making no distinction between blocked pores and other factors such as trafficking defects). For conducting channels, we then looked if activation, inactivation (including recovery), or the late component were affected. Each of these fields was recorded as ‘measured and affected’, ‘measured and not affected’, or ‘not measured’. The distinction between affected and not affected was made based on the significance (p-value) given in the paper and the wording used by the authors. Only measurements from homozygous mutant expression were included. Where possible, we calculated shifts in midpoint of activation and inactivation from the data given in the paper.
Every measurement recorded in the EP database was annotated with three fields: the type of α-subunit, the cell-type, and the presence of β1-subunits19. In order of descending frequency the cell types were HEK (HEK293 and tsA-201), Xenopus laevis oocytes and CHO, but we also found a small number of measurements in COS cells and transgenic mouse myocytes. Some papers failed to mention the cell type and were listed as ‘unknown’.
Many papers did not give precise information about the type of α-subunit used19. We found at least five different subunits. Some investigators used a construct corresponding directly to either isoform 1 or isoform 2. Isoform 1 was denoted as a; it has a glutamine at position 1077 (Q1077) and is 2016 amino acids long (GenBank accession numbers AC137587 and NM_198056). Isoform 2 was denoted b; it lacks the 1077 glutamine (Q1077del) making it 2015 amino acids long (GenBank accession numbers AY148488 and NM_000335). Isoform 2 is now held to be the most common isoform, and most often used in electrophysiological investigations27,38. A number of α-subunit clones have historically been used, which turned out to contain unintended variants. The most common of these is often called ‘hH1’ (GenBank accession number M77235) and is equal to isoform 1 except for the rare variant R1027Q. We labelled this α-subunit a*. All papers mentioning ‘hH1’ as the only reference were recorded as using a*. A less common variant corresponding to isoform 2 with a T559A substitution was labelled b*. Finally, some of the earliest papers had isoforms that turned out to contain additional rare and/or common variants, and in many cases the exact α-subunit type was not mentioned in the paper. An overview of the four main α-subunit types found is given in section 1 of the Supplement.
Relative mutation densities
To see if the mutations in our dataset were clustered in specific regions, we calculated mutation densities, as the number of mutations in the region divided by length of the region. Here, the number of mutations was counted as the number of unique reported amino-acid substitutions, and the lengths were measured as the number of amino acids in a region. We then calculated the same measure for the entire gene. By subtracting this gene-wide density from the regional densities, we arrived at relative mutation densities per region. For this regional measure, a positive value indicates there are more mutations in the region than in the overal gene, while a negative value indicates relatively fewer mutations were reported in the region.
We created two types of datasets used to test the power of machine-learning algorithms to predict cellular EP19. Both contained a number of features describing each mutation (see below). In addition, each dataset contained an outcome field describing the outcome to predict. We used both qualitative and quantitative outcomes.
A dataset was created for each of the qualitative outcomes ‘changed/unchanged’, ‘activation affected’, ‘inactivation affected’, ‘late component affected’, and ‘zero current’19. Only variants for which the outcome was known were included. Where multiple EP recordings were available, conflicts were resolved by a “majority vote” amongst the publications. Variants with an equal number of reports claiming ‘affected’ and ‘unaffected’ were not included in the dataset (resulting in the removal of 3.4% of the data).
These qualitative datasets were then split into a ‘training’ set (66.7% of the data), and an independent ‘test’ set (33.3% of the data). The training set was used to train and tune classifiers (using 10-fold cross-validation to determine and optimise the MCC), after which predictive power was assessed by evaluating the resulting model on the test set. Further details of our tuning procedure are given in section 10 of the Supplement.
For (semi-)quantitative predictions, we created a dataset of shifts in midpoint of activation or inactivation19. Instead of using numerical voltages, we discretised the voltage shifts by assigning them to one of three intervals: (−∞, −3mV), [−3mV, 3mV], (3mV, ∞). Where multiple values were available, we selected a single recording by looking at the experimental conditions used. First, recordings co-expressing β1-subunits were preferred. Secondly, we looked for recordings made with the α-subunit ‘b’. Thirdly, we prioritised recordings in HEK cells over others (since these were the most common in our dataset). Finally, any remaining conflicts were resolved by selecting the most recent recording.
Although a missense mutation can be uniquely described by its position on the gene and the replacement amino acid, this compact description is unlikely to provide enough information to be used for classification. We therefore created a varied set of features indicating aspects of the mutation that are likely to be important (e.g., position, physico-chemical properties), including factors that have often been cited in literature (e.g., proximity to the voltage sensing 4th segment).
First, we added features based on the annotations for SCN5A found on http://www.ncbi.nlm.nih.gov. These were: side (cytoplasmic, transmembrane, extracellular), segment type (terminus, segment, linker, domain linker) or region type (N-terminus, segment 1, segment linker 1-2, domain linker 1-2, etc. see Fig. 1). In addition, we added the distance (in amino-acid counts) of each position to selected regions of the protein (e.g., distance to the 4th segment, 5th segment, etc. see Fig. 1).
Next, we added features describing the difference in physico-chemical properties between the substituted amino acids19. We added the change in average residue mass39, percentage of buried residues39, van der Waals volume39, and polarity ranking39, amino-acid charge39, hydrophobicity ranking40 and α-helix propensity41. Next, we added a measure of amino-acid similarity42 and of substitution likelihood43.
Finally, we added a measure of conservedness for each position in the amino acid19. This was calculated by performing a sequence alignment of human sodium-channel genes and isoforms, as listed in section 2 of the Supplement. To further emphasise the functionally most important positions, two non-human sequences were added that have a history in cell electrophysiology: the eel sequence by Noda et al.44 and the sequence by Rosenthal et al.45 of Doryteuthis opalescens, a squid formerly known as Loligo. Sequences were aligned using Clustal 2.146 using the ‘Gonnet-250’ scoring matrix. The resulting conservedness score for each position of SCN5A was then added to the set of machine-learning features.
Weka 3.9.247 was used to apply different machine-learning methods19. To increase our chance of success, we employed methods based on very different underlying principles. We used a tree-based ‘Random forest’ classifier48, a Bayesian-statistics based ‘Naive Bayes’ classifier49, a classifier based on a multilayer perceptron (MLP, a type of neural network), a support-vector machine classifier50 and a nearest-neighbour classifier, which is an example of an instance-based learning method51. Each method was tuned to achieve the best MCC on a training dataset, before being evaluated on an independent test set. Details of this tuning are given in section 10 of the Supplement.
Performance was evaluated using three measures: accuracy (the percentage of correct guesses), the area under the receiver operating characteristic52 (or area-under-curve, AUC), and the Matthews correlation coefficient (MCC)19.
As a baseline for each measure a Zero-R classifier was used19. This simply assigns the most common class in a dataset to every new instance it evaluates. Thus, when a dataset contains 90 instances where the current is affected and 10 where it is not, the Zero-R classifier always predicts ‘affected’ and so has an accuracy of 90%. Using this baseline, another method with an apparently high accuracy of 91%, can be seen to have only made a small improvement over pure chance.
To see which features of the data were most useful for classification, we ranked them according to their information gain. This was calculated using Weka’s ‘InfoGainAttributeEval’ method53, which uses the definition given by Quinlan23,54.
Other software tools
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Relevant gene accession codes are given throughout the text.
Kléber, A. G. & Rudy, Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiological Reviews 84, 431–488 (2004).
Wilde, A. A. & Brugada, R. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circulation Research 108, 884–897 (2011).
Zimmer, T. & Surber, R. SCN5A channelopathies–an update on mutations and mechanisms. Progress in Biophysics and Molecular Biology 98, 120–136 (2008).
Hedley, P. L. et al. The genetic basis of Brugada syndrome: a mutation update. Human Mutation 30, 1256–1266 (2009).
Kapplinger, J. et al. Enhanced classification of Brugada syndrome-associated and long-QT syndrome-associated genetic variants in the SCN5A-encoded Na(v)1.5 cardiac sodium channel. Circulation: Cardiovascular Genetics 8, 582–595 (2015).
Huang, W., Liu, M., Yan, S. F. & Yan, N. Structure-based assessment of disease-related mutations in human voltage-gated sodium channels. Protein & Cell 8, 401–438 (2017).
Leong, I. U., Stuckey, A., Lai, D., Skinner, J. R. & Love, D. R. Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations. BMC Medical Genetics 16, 1 (2015).
Brunklaus, A., Ellis, R., Reavey, E., Semsarian, C. & Zuberi, S. M. Genotype phenotype associations across the voltage-gated sodium channel family. Journal of Medical Genetics 51, 650–658 (2014).
Deo, R. C. Machine learning in medicine. Circulation 132, 1920–1930 (2015).
Clancy, C. E. & Rudy, Y. Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature 400, 566–569 (1999).
Petitprez, S. et al. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome. Cardiovascular Research 78, 494–504 (2008).
Bébarová, M. et al. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation. American Journal of Physiology. Heart and Circulatory Physiology 295, H48–H58 (2008).
Hoefen, R. et al. In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models. Journal of the American College of Cardiology 60, 2182–2191 (2012).
Amin, A. S., de Groot, E. A., Ruijter, J. M., Wilde, A. A. & Tan, H. L. Exercise-induced ECG changes in Brugada syndrome. Circulation: Arrhythmia and Electrophysiology 2, 531–539 (2009).
Abriel, H. Cardiac sodium channel NaV1.5 and interacting proteins: physiology and pathophysiology. Journal of Molecular and Cellular Cardiology 48, 2–11 (2010).
Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nature Methods 7, 248–249 (2010).
Calabrese, R., Capriotti, E., Fariselli, P., Martelli, P. L. & Casadio, R. Functional annotations improve the predictive score of human disease-related mutations in proteins. Human Mutation 30, 1237–1244 (2009).
Bromberg, Y. & Rost, B. Snap: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Research 35, 3823–3835 (2007).
Clerx, M. Multi-scale Modeling and Variability in Cardiac Cellular Electrophysiology. Ph.D. thesis, Maastricht University (2017).
Catterall, W. A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13–25 (2000).
Motoike, H. K. et al. The Na + channel inactivation gate is a molecular complex a novel role of the COOH-terminal domain. Journal of General Physiology 123, 155–165 (2004).
Kapa, S. et al. Genetic testing for long-QT syndrome distinguishing pathogenic mutations from benign variants. Circulation 120, 1752–1760 (2009).
Quinlan, J. R. Induction of decision trees. Machine Learning 1, 81–106 (1986).
Walsh, R., Peters, N. S., Cook, S. A. & Ware, J. S. Paralogue annotation identifies novel pathogenic variants in patients with Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia. Journal of Medical Genetics 51, 35–44 (2014).
Amarouch, M.-Y. & Abriel, H. Cellular hyper-excitability caused by mutations that alter the activation process of voltage-gated sodium channels. Frontiers in Physiology 6 (2015).
Quinn, T. et al. Minimum information about a cardiac electrophysiology experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing. Progress in Biophysics and Molecular Biology 107, 4–10 (2011).
Makielski, J. C. et al. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circulation Research 93, 821–828 (2003).
Krawczyk, B. Learning from imbalanced data: open challenges and future directions. Progress in Artificial Intelligence 5, 221–232 (2016).
Sarkar, A. X. & Sobie, E. A. Regression analysis for constraining free parameters in electrophysiological models of cardiac cells. PLOS Computational Biology 6, e1000914 (2010).
Clatot, J. et al. Dominant-negative effect of SCN5A N-terminal mutations through the interaction of NaV1.5 α-subunits. Cardiovascular Research 96, 53–63 (2012).
Berezovsky, I. N., Guarnera, E. & Zheng, Z. Basic units of protein structure, folding, and function. Progress in Biophysics and Molecular Biology (2016).
Silverman, B. D. Three-dimensional moments of molecular property fields. Journal of Chemical Information and Computer Sciences 40, 1470–1476 (2000).
Herren, A. W., Bers, D. M. & Grandi, E. Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias. American Journal of Physiology. Heart and Circulatory Physiology 305, H431–H445 (2013).
Kapplinger, J. D. et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 7, 33–46 (2010).
Ackerman, M. J. et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 1, 600–607 (2004).
Moric, E. et al. The implications of genetic mutations in the sodium channel gene (SCN5A). Europace 5, 325–334 (2003).
Napolitano, C., Rivolta, I. & Priori, S. G. Cardiac sodium channel diseases. Clinical Chemistry and Laboratory Medicine 41, 439–444 (2003).
Ye, B., Valdivia, C. R., Ackerman, M. J. & Makielski, J. C. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiological Genomics 12, 187–193 (2003).
Simpson, R. J. Proteins and Proteomics: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2003).
Kovacs, J. M., Mant, C. T. & Hodges, R. S. Determination of intrinsic hydrophilicity/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effects. Peptide Science 84, 283–297 (2006).
Pace, C. N. & Scholtz, J. M. A helix propensity scale based on experimental studies of peptides and proteins. Biophysical Journal 75, 422–427 (1998).
Grantham, R. Amino acid difference formula to help explain protein evolution. Science 185, 862–864 (1974).
Gonnet, G. H., Cohen, M. A. & Benner, S. A. Exhaustive matching of the entire protein sequence database. Science 256, 1443–1445 (1992).
Noda, M. et al. Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence. Nature 312, 121–127 (1984).
Rosenthal, J. & Gilly, W. F. Amino acid sequence of a putative sodium channel expressed in the giant axon of the squid Loligo opalescens. Proceedings of the National Academy of Sciences of the United States of America 90, 10026–10030 (1993).
Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947–2948 (2007).
Hall, M. et al. The WEKA data mining software: an update. ACM SIGKDD Explorations Newsletter 11, 10–18 (2009).
Breiman, L. Random forests. Machine Learning 45, 5–32 (2001).
John, G. H. & Langley, P. Estimating continuous distributions in bayesian classifiers. In Proceedings of the Eleventh conference on Uncertainty in artificial intelligence, 833–345 (Morgan Kaufmann Publishers Inc, 1995).
Chang, C.-C. & Lin, C.-J. LIBSVM: a library for support vector machines. ACM Transactions on Intelligent Systems and Technology 2, 27 (2011).
Aha, D. W., Kibler, D. & Albert, M. K. Instance-based learning algorithms. Machine Learning 6, 37–66 (1991).
Mason, S. J. & Graham, N. E. Areas beneath the relative operating characteristics (roc) and relative operating levels (rol) curves: Statistical significance and interpretation. Quarterly Journal of the Royal Meteorological Society 128, 2145–2166 (2002).
Bouckaert, R. R. et al. WEKA Manual for Version 3-9-1 (The University of Waikato, 2016).
Mitchell, T. M. Machine Learning (McGraw–Hill, 1997).
Jones, E., et al. http://www.scipy.org/. [Online; accessed 2017-08-17] SciPy: Open source scientific tools for Python (2001).
P.G.A.V. is supported by The Netherlands CardioVascular Research Initiative, CVON PREDICT. J.H. is supported by a Veni grant from the Netherlands Organization for Scientific Research (ZonMw 91616057). M.C. thanks Evgueni Smirnov for his help with machine-learning techniques, and Georg Summer and Markos Xenakis for valuable discussions.
The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Clerx, M., Heijman, J., Collins, P. et al. Predicting changes to INa from missense mutations in human SCN5A. Sci Rep 8, 12797 (2018). https://doi.org/10.1038/s41598-018-30577-5
International Journal of Arrhythmia (2022)